Vetter Invests in Building an Injectable Drug Production Base in Saarland, Germany
Vetter, a pharmaceutical service provider specializing in injectable drug manufacturing, recently an...
Boehringer Ingelheim Announces Phase II Trial Results for Innovative Drug Apecotrep
German family-owned pharmaceutical company Boehringer Ingelheim today announced the results of the P...
GSK and Noetik Partner to Accelerate Oncology Drug Development
Artificial intelligence-based biotechnology company Noetik announced a five-year strategic collabora...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
US Health Agency Unveils Weight-Loss Drug Coverage Model
Wedoany.com Report-Dec.24, The U.S. Centers for Medicare and Medicaid Services announced a voluntary...
GSK to Lower Drug Prices
Wedoany.com Report-Dec.22, GSK plc has concluded an agreement with the United States government to r...
Novartis, US Government Reach Agreement to Lower Drug Prices
Wedoany.com Report-Dec.22, Novartis has entered into an agreement with the United States government ...
Roche CEO Points to Higher Future Drug Prices in Switzerland After US Deal
Wedoany.com Report-Dec.22, Agreements between pharmaceutical companies and the United States to lowe...
Japan’s Meiji Seika Pharma Collaborates With MBC Biolabs for Global Innovation in Drug Discovery
Wedoany.com Report-Dec.21, Meiji Seika Pharma, headquartered in Japan, has established a partnership...
Ambros’ $125M for Pain Disorder Drug, and Other Financings
Wedoany.com Report-Dec.19, Ambros Therapeutics, based in Irvine, California, has secured $125 millio...